ASPEN, COLO. — The molecular DNA techniques of the past few years have shed much new light on rhinovirus infection, including the fact that rhinovirus causes more lower respiratory tract infections than previously thought and that there may be a possible connection between early infection and asthma.
The new techniques, most of which utilize polymerase chain reaction technology, allow the virus to be detected and identified much more precisely than before. Some serotypes of rhinovirus cannot be cultured, said Dr. Adriana Weinberg, the medical director of the clinical virology laboratory at the University of Colorado Hospital, Denver.
Studies using these techniques now have shown that rhinovirus is associated with both bronchiolitis and pneumonia, Dr. Weinberg said.
In one study of 239 hospitalized Finnish children with bronchiolitis, rhinovirus was the second most common virus recovered from children who were less than 1 year of age (42%), just behind respiratory syncytial virus (54%). In the children who were older than 1 year, rhinovirus was more common than respiratory syncytial virus (Emerg. Infect. Dis. 2004;10:1095–101).
A few studies have looked at rhinovirus infection in children with community-acquired pneumonia (CAP). Those studies have shown that 24% of children less than 5 years of age with CAP tested positive for a rhinovirus infection. Among school-age children, 45% of pneumonia cases had a rhinovirus infection, Dr. Weinberg said.
None of the studies had control subjects, Dr. Weinberg said. There are few studies of lower respiratory tract infection and rhinovirus that do. Moreover, in many cases, the study children did have mixed infections, either another virus or a bacterial infection.
Therefore, while this information about rhinovirus and lower respiratory tract infection is obviously important, it is not necessarily in context yet, Dr. Weinberg said.
In general, mixed infections are thought to have the most severe morbidity and symptoms. And in one study that did look at whether infections were mixed or only rhinovirus and whether the “mixed” was another virus or bacteria, there was not much difference in the rates of the recovery from other viruses or bacteria—for the lower age groups at least (less than 14 months)—in the subjects who were symptomatic with a lower respiratory tract infection, compared with those who were asymptomatic, she said.
That argues that the rhinovirus is playing some role, because the rates of rhinoviral infection were different in the symptomatic and asymptomatic patients, Dr. Weinberg said.
Regarding the asthma association, Dr. Weinberg again said that there are a collection of studies that have made this observation; that is, that early infection with rhinovirus appears to increase the likelihood a child will later develop asthma.
Some of the studies have tracked the cohorts since birth, and some have been case-control studies. They have ranged in size from 100 patients to 1,314 patients and have tended to have fairly rigorous criteria for diagnosing asthma.
One theory about why rhinovirus infection would predispose toward asthma is that the infection causes some kind of physical remodeling in a developing and evolving respiratory tract. Another is that early infections prime the dendritic cells of the immune system to be hyperreactive.
Taken together and individually, the studies have suggested that severe and/or repeated lower respiratory tract infections before age 2–3 years increases the prevalence of asthma 10 times. That compares with a five-fold increase the studies have found for respiratory syncytial virus.
Of course, none of these studies provides any explanation about how this association would fit with the other, contradictory epidemiologic studies suggesting that children have increased risk of asthma when they are protected from certain infections and exposures.
“A lot of work remains to be done to fully understand the mechanism and to fully determine whether early rhinoviral infections are a cause of asthma,” Dr. Weinberg commented.
Recent work also showed that infections with rhinovirus can be severe, she noted. In a big study of the antiviral oseltamivir for influenza treatment, it was found that 19% of the patients enrolled, based on their symptoms, actually had rhinovirus infection. In those patients, the drug was not effective, but the clinical presentation was extremely similar, the investigators noted.
“Rhinovirus is much more serious than we used to think—at least in terms of morbidity,” Dr. Weinberg said.
A number of facts that were known previously about rhinovirus have been confirmed by modern study, according to Dr. Weinberg.
Those facts include the following:
▸ Rhinovirus accounts for about 30%–50% of all “common colds.”
▸ Rhinovirus is highly contagious. About two-thirds of individuals exposed to the virus will acquire an infection and develop symptoms.